Actualités de TIF

NEW PUBLICATION | TIF Recommendations Offer Guidance To Thalassaemia-Treating Physicians

NEW PUBLICATION | TIF Recommendations Offer Guidance To Thalassaemia-Treating Physicians

The newly issued publication ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an…
INTERNATIONAL THALASSAEMIA DAY | 8 May 2022

INTERNATIONAL THALASSAEMIA DAY | 8 May 2022

Every single one of us has the ability to make a difference, large or small, and together we can make real progress in raising valuable awareness about thalassaemia and its…
ROSARIO’S STORY | A True Champion of Resilience

ROSARIO’S STORY | A True Champion of Resilience

Rosario was more than eager to recount this wonderful experience to TIF for the International Thalassaemia Day 2022 and share some inspiring messages with his peers. “It is important to…
INTERNATIONAL THALASSAEMIA DAY 2022: Be Aware. Share. Care

INTERNATIONAL THALASSAEMIA DAY 2022: Be Aware. Share. Care

Visit the International Thalassaemia Day (ITD) 2022 page, now LIVE on the TIF website, to discover the idea behind the  »Be Aware. Share. Care. » theme, our fantastic campaign resources, the…
THALIA 2018-2021: Europe Is Seeing A Surge In Thalassaemia, Project Results Show

THALIA 2018-2021: Europe Is Seeing A Surge In Thalassaemia, Project Results Show

« Although thalassemia has always been endemic in Europe, especially in southern European countries such as Cyprus, Greece and Italy, the disease now knows no borders and constitutes an increasing health,…
The AAC White Paper on Pyruvate Kinase Deficiency Has Just Landed on TIF’s Website

The AAC White Paper on Pyruvate Kinase Deficiency Has Just Landed on TIF’s Website

The White Paper, based on the findings of a large international survey that looked into communication between PKD patients and caregivers and haematologists, also highlights the unmet needs and perceived…
TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care

TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care

The article discusses how the COVID-19 pandemic has magnified challenges in thalassaemia care worldwide and underscores TIF’s activities throughout the coronavirus outbreak in support of patients with haemoglobinopathies. Hematology Advisor…
TIF Guide on COVID-19 Vaccinations & Therapeutic Drugs – The December Issue

TIF Guide on COVID-19 Vaccinations & Therapeutic Drugs – The December Issue

During this last fortnight, experts have scrambled to gain an understanding of the new heavily mutated variant, what kind of symptoms and illness it can cause, and whether it undermines…
TIF Signs Agreement With Resonance Health To Deploy FerriSmart®

TIF Signs Agreement With Resonance Health To Deploy FerriSmart®

FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology. Under the Letter of Agreement, TIF will engage with National Thalassaemia…
Bouton retour en haut de la page